Corporate Profile
bluebird bio is a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. The company’s mission is to advance the care of patients with life threatening diseases worldwide. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.
Stock Quote
BLUE (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Change (%) Stock is Up 0.70 (1.70%)
Data as of 10/31/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
10/14/14bluebird bio Announces First Patient with Sickle Cell Disease Transplanted with LentiGlobin Gene TherapyPrinter Friendly Version
09/02/14bluebird bio to Present at Morgan Stanley Global Health Care ConferencePrinter Friendly Version
08/12/14bluebird bio Reports Fiscal Second Quarter 2014 Financial ResultsPrinter Friendly Version
08/05/14bluebird bio to Present at Two Upcoming Health Care ConferencesPrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.